Common Contracts

PDL BIOPHARMA, INC. as Issuer and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee SUPPLEMENTAL INDENTURE Dated as of September 17, 2019

Supplemental Indenture • September 17th, 2019 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Supplemental Indenture
• Filed
  September 17th, 2019
• Company
  PDL Biopharma, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

SUPPLEMENTAL INDENTURE, dated as of September 17, 2019 (this “Supplemental Indenture”), between PDL BioPharma, Inc., a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A, as trustee (the “Trustee”) under the Indenture dated as of September 17, 2019, between the Company and the Trustee (as amended or supplemented from time to time in accordance with the terms thereof, the “Base Indenture”).

PDL BIOPHARMA, INC. as Issuer AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee SUPPLEMENTAL INDENTURE Dated as of November 22, 2016

Supplemental Indenture • November 28th, 2016 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Supplemental Indenture
• Filed
  November 28th, 2016
• Company
  PDL Biopharma, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

SUPPLEMENTAL INDENTURE, dated as of November 22, 2016 (this “Supplemental Indenture”), between PDL BioPharma, Inc., a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A, as trustee (the “Trustee”) under the Indenture dated as of November 22, 2016, between the Company and the Trustee (as amended or supplemented from time to time in accordance with the terms thereof, the “Base Indenture”).